Biogen Inc. financial data

Symbol
BIIB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
225 Binney Street, Cambridge, MA
Fiscal year end
December 31
Former names
BIOGEN IDEC INC. (to 3/20/2015), BIOGEN IDEC INC (to 4/25/2007), IDEC PHARMACEUTICALS CORP / DE (to 11/12/2003), IDEC PHARMACEUTICALS CORP / CA (to 2/14/1997)
Latest financial report
10-Q - Q1 2025 - May 1, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 150 % -31.4%
Quick Ratio 50.2 % -20.3%
Debt-to-equity 82.1 % -17.1%
Return On Equity 8.97 % +13.4%
Return On Assets 5.32 % +21.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 147M shares +0.64%
Common Stock, Shares, Outstanding 146M shares +0.62%
Entity Public Float 33.7B USD -18.2%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 146M shares +0.62%
Weighted Average Number of Shares Outstanding, Diluted 147M shares +0.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.82B USD +1.59%
Costs and Expenses 8.06B USD -3.31%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 311M USD -33%
Income Tax Expense (Benefit) 273M USD +75.1%
Net Income (Loss) Attributable to Parent 1.48B USD +26.8%
Earnings Per Share, Basic 10.2 USD/shares +26.2%
Earnings Per Share, Diluted 10.1 USD/shares +26.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 1.4B USD -15.6%
Inventory, Net 2.27B USD -9.65%
Other Assets, Current 757M USD -35%
Assets, Current 7.63B USD +12.9%
Deferred Income Tax Assets, Net 308M USD -65.8%
Property, Plant and Equipment, Net 3.13B USD -4.36%
Operating Lease, Right-of-Use Asset 346M USD -19.1%
Intangible Assets, Net (Excluding Goodwill) 9.58B USD +15.7%
Goodwill 6.48B USD +4.01%
Other Assets, Noncurrent 559M USD -19.9%
Assets 28B USD +5.52%
Accounts Payable, Current 392M USD +1.16%
Employee-related Liabilities, Current 192M USD +17.2%
Liabilities, Current 5.3B USD +64.4%
Accrued Income Taxes, Noncurrent 162M USD -60.6%
Deferred Income Tax Liabilities, Net 133M USD -79.8%
Operating Lease, Liability, Noncurrent 323M USD -20.4%
Other Liabilities, Noncurrent 752M USD -3.27%
Liabilities 11.1B USD -2.64%
Accumulated Other Comprehensive Income (Loss), Net of Tax -175M USD -8.72%
Retained Earnings (Accumulated Deficit) 19.5B USD +8.21%
Stockholders' Equity Attributable to Parent 14.8B USD +10.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 17B USD +11.6%
Liabilities and Equity 28B USD +5.52%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 259M USD -53.1%
Net Cash Provided by (Used in) Financing Activities -23M USD +94.8%
Net Cash Provided by (Used in) Investing Activities -47.3M USD +28.3%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 170M shares +0.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.6B USD +142%
Deferred Tax Assets, Valuation Allowance 1.01B USD -20.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 421M USD -14.2%
Depreciation 289M USD +10.5%
Payments to Acquire Property, Plant, and Equipment 37.1M USD -19.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.47B USD +24.4%
Lessee, Operating Lease, Liability, to be Paid 505M USD -14.7%
Property, Plant and Equipment, Gross 5.85B USD +2.45%
Operating Lease, Liability, Current 86.4M USD -4.32%
Lessee, Operating Lease, Liability, to be Paid, Year Two 88.5M USD -7.91%
Lessee, Operating Lease, Liability, to be Paid, Year One 103M USD -2.64%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -27.8M USD -170%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 83.8M USD -17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 88.3M USD +5.75%
Deferred Tax Assets, Operating Loss Carryforwards 1.36B USD -20.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 8M shares 0%
Unrecognized Tax Benefits 186M USD +7.44%
Lessee, Operating Lease, Liability, to be Paid, Year Four 50.2M USD -41.7%
Additional Paid in Capital 630M USD +91.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 183M USD +24.2%
Deferred Tax Assets, Net of Valuation Allowance 2.93B USD +0.02%
Share-based Payment Arrangement, Expense -302M USD -9.88%
Interest Expense 241M USD -4.93%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%